what's the difference between glp1 and semaglutide Is Same as Ozempic? Tirzepatide vs. Semaglutide: Which GLP-1

Natali, A., Nesti, L., Tric, D

N Engl J Med 1999;341:1639-44

Indication for SOLIQUA 100/33 SOLIQUA 100/33 (insulin glargine and lixisenatide) is a combination of insulin glargine, an insulin analog, and lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

Eli Lilly and Novo Nordisk are the undisputed leaders in the market for GLP-1 drugs, a class of medications used to treat both diabetes and obesity

By providing customized formulations, allergen-free preparations, enhanced patient adherence support, and collaborative clinical partnerships all pursuant to valid patient-specific prescriptions compliant compounding pharmacies can be a meaningful part of a well-structured semaglutide program